We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Urinary Continence Index for Prediction of Urinary Incontinence in Older Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01479816
Recruitment Status : Completed
First Posted : November 24, 2011
Last Update Posted : July 21, 2016
Information provided by (Responsible Party):

Study Description
Brief Summary:
This study will analyse existing data to establish a clinically useful index to predict those women who are more likely to become incontinent. This would create significant opportunities for focused prevention and early intervention strategies.

Condition or disease
Urinary Incontinence

Study Design

Study Type : Observational
Actual Enrollment : 702 participants
Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Study Start Date : September 2011
Primary Completion Date : September 2015
Study Completion Date : December 2015

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Primary Outcome Measures :
  1. Index Estimation for Urinary Incontinence Prediction [ Time Frame: 2 years ]
    Several risk factors identified can serve as an index in predicting the development of urinary incontinence in elderly women.

Secondary Outcome Measures :
  1. Predictive Reliability of Urinary Incontinence Index and its Validation [ Time Frame: 3 years ]
    The urinary continence index developed in Outcome measure 1 will reliably predict the development of urinary incontinence in women when tested against existing datasets.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   55 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women 55 years and older

Inclusion Criteria:

  • Women

Exclusion Criteria:

  • Men
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01479816

United States, Michigan
Oakland University
Rochester, Michigan, United States, 48309
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
Ananias Diokno
National Institute on Aging (NIA)
Principal Investigator: Ananias Diokno, MD William Beaumont Hospitals
More Information

Responsible Party: Ananias Diokno, Principal Investigator, William Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT01479816     History of Changes
Other Study ID Numbers: E2011-047
1R01AG038673 ( U.S. NIH Grant/Contract )
First Posted: November 24, 2011    Key Record Dates
Last Update Posted: July 21, 2016
Last Verified: July 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Ananias Diokno, William Beaumont Hospitals:

Additional relevant MeSH terms:
Urinary Incontinence
Urination Disorders
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms
Behavioral Symptoms
Elimination Disorders
Mental Disorders